- 英文名称(6S,9S,12S,15S,18S)-1,1,6-Triamino-9-(4-Aminobutyl)-12-(Carboxymethyl)-18-(4-Hydroxybenzyl)-15-Isopropyl-7,10,13,16-Tetraoxo-2,8,11,14,17-Pentaazanonadec-1-En-19-Oic Acid--Acetic Acid (1/1)
- 中文名称胸腺五肽醋酸盐
- IUPAC名称(6S,9S,12S,15S,18S)-1,1,6-triamino-9-(4-aminobutyl)-12-(carboxymethyl)-18-(4-hydroxybenzyl)-15-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadec-1-en-19-oic acid--acetic acid (1/1)
- 其它别名Acetic Acid:(3S)-3-[[(2S)-6-Amino-2-[[(2S)-2-Amino-5-(Diaminomethylideneamino)Pentanoyl]Amino]Hexanoyl]Amino]-4-[[(2S)-1-[[(1S)-1-Carboxy-2-(4-Hydroxyphenyl)Ethyl]Amino]-3-Methyl-1-Oxobutan-2-Yl]Amino]-4-Oxobutanoic Acid
- CAS编号89318-88-7
- MFCD编号:MFCD00133107
- 分子式:C32H53N9O11分子量:739.83
- 产品CID: 1914456
海关参考信息
- 2902600000-乙苯
2905121000-正丙醇
2905130000-正丁醇
2912110000-甲醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:EP-0324659-B1
优先权日:1988-01-14
标 题 :Enzymatic process for producing immunomodulating pentapeptides and intermediates for use in the process
发明人:AASMUL-OLSEN STIG; ANDERSEN ANDERS J
权利人:CARLBIOTECH LTD AS
摘要:Synthesis of peptides R1-A-B-C-D-E-R2 wherein A, B, C, D and E represent amino acid residues coupled with peptide bonds and A is a omega -amino-or omega -guanidino substituted basic L- or D-amino acid residue or a desamino derivative thereof, B is a omega -amino- or omega -guanidino substituted basic L-amino acid residue, L-Pro or L-dehydroPro, preferably Asp or Glu, C is an acidic L- or D-amino acid residue, preferably Asp or Glu, D is an unpolar, hydrophobic aliphatic or aromatic aryl- or aralkyl group containing L-amino acid residue, preferably Val, Ile or Leu, E is an unpolar, hydrophobic aliphatic or aromatic aryl- or aralkyl group containing L- or D-amino acid residue or a decarboxy derivative thereof, preferably Tyr, Trp, Phe, His or Val, R1 is H or an alpha -amino substituting group, and R2 is OH or an alpha -carboxy substituting group, by sequential coupling of reactive derivatives of said amino acids and/or by fragment coupling of reactive oligopeptide derivatives on the basis of said amino acids. At least one of these coupling reactions is carried out in a completely or partly aqueous medium at pH 3-12, in the presence of a proteolytic enzyme capable of catalyzing the formation of a peptide which, if desired, is coupled with a reactive amino acid derivative or peptide derivative in the presence of the same or another proteolytic enzyme, further enzymatic or chemical coupling reactions being carried out, if necessary. The process, which is particularly suited for synthesizing the immunomodulating pentapeptides thymopentin and spleninopentin and their analogues, comprises several coupling strategies, the preferred enzymes for use in these strategies i.a. including thermolysin, trypsin, subtilisin, carboxypeptidase Y, elastase and bromelain. The process i.a. uses the intermediates Z1ABOR, Z1ABC(OR min )(OR sec ) and Z1ABC(OR)OH, wherein Z1 has the same meaning as R1, and R is alkyl or benzyl.